CS216512B2 - Method of making the derivatives of the pyrido + l 2,1-b+p chinazolinone - Google Patents
Method of making the derivatives of the pyrido + l 2,1-b+p chinazolinone Download PDFInfo
- Publication number
- CS216512B2 CS216512B2 CS797083A CS708379A CS216512B2 CS 216512 B2 CS216512 B2 CS 216512B2 CS 797083 A CS797083 A CS 797083A CS 708379 A CS708379 A CS 708379A CS 216512 B2 CS216512 B2 CS 216512B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- pyrido
- group
- methyl
- amino
- physiologically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Fats And Perfumes (AREA)
- Organic Insulating Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782845766 DE2845766A1 (de) | 1978-10-18 | 1978-10-18 | Pyrido eckige klammer auf 2,1-b eckige klammer zu -chinazolinon-derivate, ihre herstellung und verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS216512B2 true CS216512B2 (en) | 1982-11-26 |
Family
ID=6052696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS797083A CS216512B2 (en) | 1978-10-18 | 1979-10-18 | Method of making the derivatives of the pyrido + l 2,1-b+p chinazolinone |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4457927A (xx) |
| EP (1) | EP0011142B1 (xx) |
| JP (1) | JPS5557588A (xx) |
| AT (1) | ATE2146T1 (xx) |
| AU (1) | AU529643B2 (xx) |
| CA (1) | CA1130805A (xx) |
| CS (1) | CS216512B2 (xx) |
| DD (1) | DD147242A5 (xx) |
| DE (2) | DE2845766A1 (xx) |
| DK (1) | DK154297C (xx) |
| EG (1) | EG14028A (xx) |
| ES (1) | ES8103745A1 (xx) |
| FI (1) | FI793229A (xx) |
| FR (1) | FR2439199A1 (xx) |
| GB (1) | GB2034705B (xx) |
| GR (1) | GR73819B (xx) |
| IE (1) | IE48852B1 (xx) |
| IL (1) | IL58474A0 (xx) |
| NO (1) | NO793344L (xx) |
| NZ (1) | NZ191828A (xx) |
| PL (3) | PL123075B1 (xx) |
| PT (1) | PT70329A (xx) |
| RO (1) | RO78339A (xx) |
| SU (1) | SU1001857A3 (xx) |
| ZA (1) | ZA795559B (xx) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3300477A1 (de) * | 1983-01-08 | 1984-07-12 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue heterocyclische verbindungen, ihre herstellung und verwendung |
| US4587339A (en) * | 1983-10-14 | 1986-05-06 | Sun Chemical Corporation | Nickel complex pigments of bis-azomethines |
| CZ281628B6 (cs) * | 1991-07-29 | 1996-11-13 | Warner-Lambert Company | Deriváty chinazolinu a farmaceutické přípravky na jejich bázi |
| US5858694A (en) * | 1997-05-30 | 1999-01-12 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of cancerous lesions |
| CA2238283C (en) | 1997-05-30 | 2002-08-20 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions |
| US6410584B1 (en) * | 1998-01-14 | 2002-06-25 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells with indole derivatives |
| US6200771B1 (en) | 1998-10-15 | 2001-03-13 | Cell Pathways, Inc. | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
| US6130053A (en) * | 1999-08-03 | 2000-10-10 | Cell Pathways, Inc. | Method for selecting compounds for inhibition of neoplastic lesions |
| US6133271A (en) * | 1998-11-19 | 2000-10-17 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives |
| US6187779B1 (en) | 1998-11-20 | 2001-02-13 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives |
| US6369092B1 (en) | 1998-11-23 | 2002-04-09 | Cell Pathways, Inc. | Method for treating neoplasia by exposure to substituted benzimidazole derivatives |
| US6077842A (en) * | 1998-11-24 | 2000-06-20 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives |
| US6034099A (en) * | 1998-11-24 | 2000-03-07 | Cell Pathways, Inc. | Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones |
| US6486155B1 (en) | 1998-11-24 | 2002-11-26 | Cell Pathways Inc | Method of inhibiting neoplastic cells with isoquinoline derivatives |
| US6025394A (en) | 1999-01-29 | 2000-02-15 | Cell Pathways, Inc. | Method for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcohols |
| US6020379A (en) * | 1999-02-19 | 2000-02-01 | Cell Pathways, Inc. | Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia |
| US6555547B1 (en) | 2000-02-28 | 2003-04-29 | Cell Pathways, Inc. | Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative |
| US6569638B1 (en) | 2000-03-03 | 2003-05-27 | Cell Pathways, Inc | Method for screening compounds for the treatment of neoplasia |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1064259A (en) * | 1963-12-19 | 1967-04-05 | Union Pharma Scient Appl | New derivatives of 2-anilino-nicotinic acid and process for their preparation |
| US4033961A (en) * | 1975-10-07 | 1977-07-05 | Warner-Lambert Company | Pyrido[2-1-b]quinazolin-ones and their methods of preparation |
| DE2557425C2 (de) * | 1975-12-19 | 1987-03-19 | C.H. Boehringer Sohn, 6507 Ingelheim | 11-Oxo-11-H-pyrido[2,1-b]-chinazolin-2-carbonsäure und ihre Salze, Verfahren zu ihrer Herstellung und Arzneimittel |
| US4066767A (en) * | 1976-11-01 | 1978-01-03 | Warner-Lambert Company | 8-(1H-Tetrazol-5-yl)-11H-pyrido[2,1-b]quinazolin-11-ones and method of treating bronchial asthma using them |
| PH13915A (en) * | 1977-03-24 | 1980-11-04 | Hoffmann La Roche | Chinazoline derivatives |
-
1978
- 1978-10-18 DE DE19782845766 patent/DE2845766A1/de not_active Withdrawn
-
1979
- 1979-10-11 NZ NZ191828A patent/NZ191828A/xx unknown
- 1979-10-15 DD DD79216232A patent/DD147242A5/de unknown
- 1979-10-15 AT AT79103974T patent/ATE2146T1/de not_active IP Right Cessation
- 1979-10-15 DE DE7979103974T patent/DE2964431D1/de not_active Expired
- 1979-10-15 EP EP79103974A patent/EP0011142B1/de not_active Expired
- 1979-10-16 RO RO7998984A patent/RO78339A/ro unknown
- 1979-10-16 PL PL1979227126A patent/PL123075B1/pl unknown
- 1979-10-16 PL PL1979218993A patent/PL119174B1/pl unknown
- 1979-10-16 PL PL1979227124A patent/PL123430B1/pl unknown
- 1979-10-16 GR GR60275A patent/GR73819B/el unknown
- 1979-10-16 AU AU51832/79A patent/AU529643B2/en not_active Expired - Fee Related
- 1979-10-17 PT PT70329A patent/PT70329A/pt unknown
- 1979-10-17 DK DK438379A patent/DK154297C/da active
- 1979-10-17 CA CA337,796A patent/CA1130805A/en not_active Expired
- 1979-10-17 IL IL58474A patent/IL58474A0/xx unknown
- 1979-10-17 NO NO793344A patent/NO793344L/no unknown
- 1979-10-17 IE IE1969/79A patent/IE48852B1/en unknown
- 1979-10-17 SU SU792832051A patent/SU1001857A3/ru active
- 1979-10-18 FI FI793229A patent/FI793229A/fi not_active Application Discontinuation
- 1979-10-18 EG EG624/79A patent/EG14028A/xx active
- 1979-10-18 ZA ZA00795559A patent/ZA795559B/xx unknown
- 1979-10-18 ES ES485162A patent/ES8103745A1/es not_active Expired
- 1979-10-18 CS CS797083A patent/CS216512B2/cs unknown
- 1979-10-18 FR FR7925883A patent/FR2439199A1/fr not_active Withdrawn
- 1979-10-18 JP JP13363479A patent/JPS5557588A/ja active Granted
- 1979-10-18 GB GB7936147A patent/GB2034705B/en not_active Expired
-
1982
- 1982-12-22 US US06/452,009 patent/US4457927A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ZA795559B (en) | 1980-09-24 |
| ES485162A0 (es) | 1981-03-16 |
| IL58474A0 (en) | 1980-01-31 |
| PL119174B1 (en) | 1981-12-31 |
| FR2439199A1 (fr) | 1980-05-16 |
| DD147242A5 (de) | 1981-03-25 |
| PT70329A (de) | 1979-11-01 |
| AU5183279A (en) | 1980-04-24 |
| NO793344L (no) | 1980-04-21 |
| IE791969L (en) | 1980-04-18 |
| ATE2146T1 (de) | 1983-01-15 |
| GR73819B (xx) | 1984-05-03 |
| GB2034705B (en) | 1982-12-08 |
| RO78339A (ro) | 1982-04-12 |
| JPS5557588A (en) | 1980-04-28 |
| DK154297C (da) | 1989-03-28 |
| ES8103745A1 (es) | 1981-03-16 |
| PL123430B1 (en) | 1982-10-30 |
| IE48852B1 (en) | 1985-05-29 |
| PL218993A1 (xx) | 1980-06-16 |
| GB2034705A (en) | 1980-06-11 |
| NZ191828A (en) | 1983-03-15 |
| FI793229A (fi) | 1980-04-19 |
| EG14028A (en) | 1982-09-30 |
| EP0011142A1 (de) | 1980-05-28 |
| AU529643B2 (en) | 1983-06-16 |
| DK154297B (da) | 1988-10-31 |
| EP0011142B1 (de) | 1982-12-29 |
| CA1130805A (en) | 1982-08-31 |
| DE2964431D1 (en) | 1983-02-03 |
| SU1001857A3 (ru) | 1983-02-28 |
| DE2845766A1 (de) | 1980-04-30 |
| DK438379A (da) | 1980-04-19 |
| PL123075B1 (en) | 1982-09-30 |
| JPS634537B2 (xx) | 1988-01-29 |
| US4457927A (en) | 1984-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS216512B2 (en) | Method of making the derivatives of the pyrido + l 2,1-b+p chinazolinone | |
| US5118686A (en) | Phenylpyrimidones | |
| KR870001201B1 (ko) | 피롤로벤즈이미다졸 유도체의 제조방법 | |
| JP2527917B2 (ja) | 治療薬 | |
| JPH0314315B2 (xx) | ||
| JPH0853447A (ja) | 新規１，３−ジヒドロ−２Ｈ−ピロロ〔２，３−ｂ〕ピリジン−２−オンとオキサゾロ〔４，５−ｂ〕ピリジン−２（３Ｈ）−オン化合物、その製造方法及びそれらを含む薬剤組成物 | |
| US4782055A (en) | Imidazopyridine compounds useful in the treatment of ulcers | |
| PL125321B1 (en) | Process for preparing novel,condensed derivatives of pyrimidines | |
| JPH05208978A (ja) | １，２−ジヒドロ−３Ｈ−ピロロ〔１，２−α〕ピロール−１−カルボン酸エステルの５位のアロイル化方法 | |
| NO147879B (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-substituerte benzimidazoler | |
| JPH0341068A (ja) | インドールカルボン酸誘導体の製造法 | |
| JPH05117273A (ja) | 医薬化合物 | |
| HU186951B (en) | Process for producing substitited thizaolo-bracket-3,2-a-bracket closed-parimidines and pharmaceutical compositions containing them | |
| JPS63208580A (ja) | Ｎ置換３，４−ジヒドロピリミジン誘導体および循環器系疾患治療剤 | |
| HU179391B (en) | Process for producing thiasolo-square bracket-2,3-b-square bracket closed-quinasoline derivatives | |
| EP0244352B1 (en) | Pyrido[4,3-d]pyrimidine derivatives | |
| KR910001134B1 (ko) | 피라졸로[1,5-a]피리딘 유도체의 제조방법 | |
| JP2651912B2 (ja) | イミダゾール誘導体、それらの製造法及び薬剤としての使用 | |
| CA1073905A (en) | Pyrazolo (1,5-a) pyrido (3,2-e) pyrimidine-7-carboxylic acid derivatives | |
| US4044134A (en) | Fused pyrimidin-4(3H)-ones as antiallergy agents | |
| US3974161A (en) | Fused pyrimidin-4(3H)-ones as antiallergy agents | |
| Habib et al. | Ylides of heterocycles. VII.. I‐, N‐, P‐and S‐ylides of pyrimidones | |
| EP0066124B1 (en) | Pyridothienopyridazine compounds | |
| JPS6110587A (ja) | １−アザキサントン−３−カルボン酸誘導体およびその製造法 | |
| JPH07500102A (ja) | 医薬用ピリジノール誘導体 |